Updates In CLL Treatments
John C. Byrd, MD, a professor of Medicine at The Ohio State University Comprehensive Cancer Center, discusses updates in the treatment of CLL.
John C. Byrd, MD, a professor of Medicine at The Ohio State University Comprehensive Cancer Center, discusses updates in the treatment of CLL.
Clinical Pearls:
- Patient-friendly therapies are changing the lives of patients with CLL.
- These oral therapies are active and successfully controlling the disease for an extended period of time.
- By combining new, active agents, physicians are moving closer to finding a cure for patients with CLL.
- With updates in treatment options, physicians can now start to move away from using chemotherapy to treat patients with CLL.
Recent Videos
Related Content
In CLL/SLL, Zanubrutinib Linked to Lower Switch Rates vs Other BTK Inhibitors
September 12th 2024Article
Findings from a real-world study showed that zanubrutinib was associated with lower rates of treatment switching and patients receiving subsequent therapy compared with acalabrutinib and ibrutinib in patients with CLL or SLL.
Read More
